Amanote Research
Register
Sign In
Acute Treatment of Moderate to Severe Depression With Hypericum Extract WS 5570 (St John's Wort): Randomised Controlled Double Blind Non-Inferiority Trial Versus Paroxetine
BMJ
doi 10.1136/bmj.330.7494.759-a
Full Text
Open PDF
Abstract
Available in
full text
Date
March 31, 2005
Authors
Unknown
Publisher
BMJ
Related search
Comparison of St John's Wort and Imipramine for Treating Depression: Randomised Controlled Trial
BMJ
Antibiotic Treatment for 6 Days Versus 12 Days in Patients With Severe Cellulitis: A Multicentre Randomised, Double-Blind, Placebo-Controlled, Non-Inferiority Trial
Clinical Microbiology and Infection
Medicine
Infectious Diseases
Microbiology
St John's Wort for Depression
BMJ
Oral Versus Intravenous High-Dose Methylprednisolone for Treatment of Relapses in Patients With Multiple Sclerosis (COPOUSEP): A Randomised, Controlled, Double-Blind, Non-Inferiority Trial
The Lancet
Medicine
St John's Wort (Hypericum Perforatum): Drug Interactions and Clinical Outcomes
British Journal of Clinical Pharmacology
Pharmacology
Reduction of Hyperbilirubinemia With Hypericum Extract (St. John's Wort) in a Patient With Crigler-Najjar Syndrome Type II
British Journal of Clinical Pharmacology
Pharmacology
Intramuscular Versus Oral Dexamethasone for the Treatment of Moderate-To-Severe Croup: A Randomized, Double-Blind Trial
Academic Emergency Medicine
Medicine
Emergency Medicine
Endocrinological Effects of High-Dose Hypericum Perforatum Extract WS 5570 in Healthy Subjects
Neuropsychobiology
Psychiatry
Mental Health
Physiological Psychology
Neuropsychology
Biological Psychiatry
Full Versus Half Dose of Antenatal Betamethasone to Prevent Severe Neonatal Respiratory Distress Syndrome Associated With Preterm Birth: Study Protocol for a Randomised, Multicenter, Double Blind, Placebo-Controlled, Non-Inferiority Trial (BETADOSE)
BMC Pregnancy and Childbirth
Gynecology
Obstetrics